journal article Jan 01, 2002

Current Understandings of the Molecular Genetics of Gestational Trophoblastic Diseases

Placenta Vol. 23 No. 1 pp. 20-31 · Elsevier BV
View at Publisher Save 10.1053/plac.2001.0744
Topics

No keywords indexed for this article. Browse by subject →

References
84
[1]
Ahmed "Comparative genomic hybridization studies in hydatidiform moles and choriocarcinoma: amplification of 7q21–q31 and loss of 8p12–p21 in choriocarcinoma" Cancer Genet Cytogenet (2000) 10.1016/s0165-4608(99)00103-x
[2]
Alarcon "Modulation of c-myc activity and apoptosis in vivo" Cancer Res (1996)
[3]
Ariel "Relaxation of imprinting in trophoblastic disease" Gynecol Oncol (1994) 10.1006/gyno.1994.1118
[4]
Arima "Association of IGF2 and H19 imprinting with choriocarcinoma development" Cancer Genet Cytogenet (1997) 10.1016/s0165-4608(96)00221-x
[5]
Azuma "Application of gene amplification by polymerase chain reaction to genetic analysis of molar mitochondrial DNA: the detection of anuclear empty ovum as the cause of complete mole" Gynecol Oncol (1991) 10.1016/0090-8258(91)90080-o
[6]
Bae "Telomerase activity in complete hydatidiform mole" Am J Obstet Gynecol (1999) 10.1016/s0002-9378(99)70208-5
[7]
Barton "Role of maternal and paternal genomes in mouse development" Nature (1984) 10.1038/311374a0
[8]
Bauer "c-erbB-2 amplification and expression in gestational trophoblastic disease correlates with DNA content and karyotype" Gen Diagn Pathol (1997)
[9]
Cheung "Gestational trophoblastic disease" (1995)
[10]
Cheung "Expression of c-myc and c-fms oncogenes in trophoblastic cells in hydatidiform mole and normal human placenta" J Clin Pathol (1993) 10.1136/jcp.46.3.204
[11]
Cheung "Detection of heterozygous XY complete hydatidiform mole by chromosome in situ hybridisation" Gynecol Oncol (1994) 10.1006/gyno.1994.1311
[12]
Cheung "Expression of the p53 gene in trophoblastic cells in hydatidiform moles and normal human placentas" J Reprod Med (1994)
[13]
Cheung "p21WAF1/CIP1 expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and p53 gene expression" J Clin Pathol (1998) 10.1136/jcp.51.2.159
[14]
Cheung "Immunohistochemical and mutational analysis of p53 tumour suppressor gene in gestational trophoblastic disease—correlation with mdm2, proliferation index and clinicopathological parameters" Int J Gynecol Cancer (1999) 10.1046/j.1525-1438.1999.09904.x
[15]
Cheung "Telomerase activity in gestational trophoblastic disease" J Clin Pathol (1999) 10.1136/jcp.52.8.588
[16]
Cheville "p53 expression in placentas with hydropic change and hydatidiform moles" Mod Pathol (1996)
[17]
Chilosi "Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease" Lab Invest (1998)
[18]
Chiu "Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome— assessment by M30 cytoDeath antibody which recognizes caspase cleavage site within cytokeratin 18" Histopathol
[19]
Chun "Choriocarcinoma in Hong Kong" J R Coll Surg Edin (1974)
[20]
Diebold "c-myc expression in early human placenta: a critical evaluation of its localization" Virchows Arch (1991) 10.1007/bf02890406
[21]
Edwards "Complete hydatidiform moles combine maternal mitochondria with a paternal nuclear genome" Ann Hum Genet (1984) 10.1111/j.1469-1809.1984.tb01007.x
[22]
Feinberg "Genomic imprinting and cancer" (1998)
[23]
Fisher "Heterozygous complete hydatidiform moles: do they have a worse prognosis than homozygous complete moles" Lancet (1984) 10.1016/s0140-6736(84)92047-6
[24]
Fisher "Gestational trophoblastic disease— molecular and genetic studies" J Reprod Med (1998)
[25]
Fritsche "Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents" Oncogene (1993)
[26]
Fulop "DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases" Oncogene (1998) 10.1038/sj.onc.1201955
[27]
Fulop "p53, p21, Rb and mdm 2 oncoproteins: expression in normal placenta, partial and complete mole, and choriocarcinoma" J Reprod Med (1998)
[28]
Fulop "c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins: expression in normal placenta, partial and complete mole, and choriocarcinoma" J Reprod Med (1998)
[29]
Giannoukakis "Parental genomic imprinting of the human IGF2 gene" Nat Genet (1993) 10.1038/ng0593-98
[30]
Halperin "Expression of the p53 gene and apoptosis in gestational trophoblastic disease" Placenta (2000) 10.1053/plac.1999.0442
[31]
Jacobs "Human triploidy: relationship between parental origin of the additional haploid complement and development of partial hydatidiform mole" Ann Hum Genet (1982) 10.1111/j.1469-1809.1982.tb00714.x
[32]
Jinno "Establishment of functional imprinting of H19 gene in human developing placentae" Nat Genet (1995) 10.1038/ng0795-318
[33]
Kajii "Androgenetic origin of hydatidiform mole" Nature (1977) 10.1038/268633a0
[34]
Kajii "XY and XX complete moles: clinical and morphologic correlation" Am J Obstet Gynecol (1984) 10.1016/s0002-9378(84)80110-6
[35]
Lawler "Genetic studies in hydatidiform mole with clinical correlations" Placenta (1987) 10.1016/0143-4004(87)90041-5
[36]
Lawler "A prospective study of hydatidiform mole" Am J Obstet Gynecol (1991) 10.1016/0002-9378(91)90698-q
[37]
Lawler "Genetic studies on hydatidiform moles. I. The origin of partial moles" Cancer Genet Cytogenet (1982) 10.1016/0165-4608(82)90096-6
[38]
Lawler "Genetic studies of complete and partial hydatidiform moles" Lancet (1979) 10.1016/s0140-6736(79)91632-5
[39]
Lee "p53 expression in gestational trophoblastic disease" Int J Gynecol Pathol (1995) 10.1097/00004347-199504000-00005
[40]
Leibovitch "The human ASM (adult skeletal muscle) gene: expression and chromosomal assignment to 11p15" Biochem Biophys Res Commun (1991) 10.1016/s0006-291x(05)81329-4
[41]
Levine "The p53 tumor suppressor gene" Nature 10.1038/351453a0
[42]
Levine "The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis" Br J Cancer (1994) 10.1038/bjc.1994.76
[43]
Lipponen "Expression of c-myc protein is related to cell proliferation and expression of growth factor receptors in transitional cell bladder cancer" J Pathol (1995) 10.1002/path.1711750208
[44]
Ma "Gestational trophoblastic disease in Hong Kong" Semin Oncol (1982)
[45]
Makino "Cytological studies of tumours. XLI. Chromosomal instability in human chorionic lesions" Okajimas Folia Anatomica Japonica (1965) 10.2535/ofaj1936.40.4-6_439
[46]
Marzusch "Expression of the p53 tumour suppressor gene in human placenta: an immunohistochemical study" Placenta (1995) 10.1016/0143-4004(95)90086-1
[47]
Matsuda "Human chromosome 7 carries a putative tumor suppressor gene(s) involved in choriocarcinoma" Oncogene (1997) 10.1038/sj.onc.1201461
[48]
Mok "Molecular cloning of differentially expressed genes in human epithelial ovarian cancer" Gynecol Oncol (1994) 10.1006/gyno.1994.1040
[49]
Momand "Mdm-2: ‘big brother’ of p53" J Cell Biochem (1997) 10.1002/(sici)1097-4644(19970301)64:3<343::aid-jcb1>3.0.co;2-v
[50]
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

Jamil Momand, Gerard P. Zambetti, David C. Olson et al.

Cell 1992 10.1016/0092-8674(92)90644-r

Showing 50 of 84 references

Metrics
77
Citations
84
References
Details
Published
Jan 01, 2002
Vol/Issue
23(1)
Pages
20-31
License
View
Cite This Article
H.W. Li, S.W. Tsao, A.N.Y. Cheung (2002). Current Understandings of the Molecular Genetics of Gestational Trophoblastic Diseases. Placenta, 23(1), 20-31. https://doi.org/10.1053/plac.2001.0744
Related

You May Also Like